RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.4103/ajns.AJNS_229_20
Trigeminal neuralgia secondary to cerebellar arteriovenous malformation: A report of two cases
Trigeminal neuralgia (TN) secondary to cerebellar arteriovenous malformation (cAVM) is a rare condition with only few reports existing in the literatures. Given to its rarity, the treatment armamentarium is still controversial. We reported our experiences treated two cases of TN secondary to cAVM using different strategies. The first case was successfully treated by a combination of gamma knife radiosurgery and microvascular decompression (MVD) of the trigeminal nerve. The second case was successfully treated by one-step microsurgical AVM resection and MVD of the trigeminal nerve. Postoperative immediate pain relief was achieved in both patients. Microsurgical procedure is still playing an important role in treating TN secondary to cAVM.
#
Key-words:
Cerebellar arteriovenous malformation - microsurgery - multimodal treatment - trigeminal neuralgiaIntroduction
Trigeminal neuralgia (TN) classically presents as a brief and severe paroxysmal facial pain involving one or more trigeminal nerve divisions. TN has an incidence of 4–5/100,000 and up to 25/100,000 in the geriatric population.[[1]] The majority of TN (80%–90%) is caused by a neurovascular compression at the Obersteiner–Redlich (OR) zone which is located approximately 1–3 mm distal to the trigeminal nerve origin at the brainstem. Secondary TN is due to any underlying disease resulting in compression or irritation at the OR zone such as an arteriovenous malformation (AVM), brain tumor, aneurysm, and multiple sclerosis.
Cerebellar AVMs (cAVMs) are rare, accounting for 7%–15% of all intracranial AVMs. The most common clinical presentation is brain hemorrhage.[[2]],[[3]] A cAVM presenting with TN is extremely rare with only 17 published in the English literature over 60 years.[[4]],[[5]] Endovascular embolization and/or stereotactic radiosurgery have been the most common method of treatment in the past 20 years. Surgery was only reported in five cases, and the total AVM resection was achieved in just two cases. A cAVM presenting with TN is a rare and complex clinical entity, and multimodal treatment must consider not only patient's debilitating facial pain but also the natural history of cAVM. To date, there is no consensus on the optimal treatment for these cases.
In this study, we reported our experiences in the management of two patients presenting with secondary TN due to cAVM. Our treatment strategies were tailored according to individual clinical status and our local treatment capabilities.
#
Case Reports
Case #1
A 39-year-old Jehovah witness female presented with progressive right-sided V2 and V3 TN over the past 3 years. Magnetic resonance imaging (MRI) and digital subtraction angiogram (DSA) showed a grade 5 right cAVM with feeding vessels from the right superior cerebellar artery (SCA), anterior inferior cerebellar artery (AICA), and posterior inferior cerebellar artery [[Figure 1]]a and [[Figure 1]]b. The compression of the trigeminal nerve was suspected to be from the right SCA, AICA, and pontomesencephalic vein, which represented the main venous drainage from the AVM. The patient was referred to gamma knife radiosurgery (GKRS) service to treat both her AVM and TN. She received 80 Gy at the 100% isodose line for her trigeminal nerve and 20 Gy at the 45% isodose line for her AVM [[Figure 1]]c and [[Figure 1]]d. After GKRS, the pain was relieved for several weeks but relapsed with gradual pain worsening in frequency, intensity, and duration. Gasserian ganglion glycerol injection and medical therapy with carbamazepine 900 mg, oxcarbazepine 600 mg, and pregabalin 300 mg were utilized without effective result. The patient then returned to our clinic at 18 months after GKRS in poor clinical condition with modified Rankin Scale (mRS) of 3, due to malnourishment, general weakness, and severe facial pain. A follow-up DSA was performed and showing significant obliteration of the AVM [[Figure 1]]e and [[Figure 1]]f. Due to the improvement of the AVM status and her refusal to consent to blood transfusion, we decided to perform a microvascular decompression (MVD).
![](https://www.thieme-connect.de/media/10.1055-s-00053244/202003/thumbnails/10-4103-ajns-ajns-229-20_293724-i293724-1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
A standard right-sided retrosigmoid approach was performed. A 3 cm craniotomy bone flap was executed. Intraoperative finding showed that the OR zone of the fifth nerve was severely compressed by the SCA and dilated pontomesencephalic vein [[Figure 1]]g and [[Figure 1]]h. The separation of these vessels was challenging due to the adherence of the arachnoid and neurovascular structures which we believed to be an effect of GKRS.
Postoperatively, the patient had immediate pain relief and was discharged at postoperative day 4 with mRS 1. Follow-up on 12, 24, and 60 months showed that the patient was still free of pain and medication and a mRS 0 at all-time points.
#
Case #2
A 31-year-old female presented with right-sided facial pain in the V2 dermatome for 4 years. MRI of the brain showed a grade 3 cAVM at the right anterior lobe [[Figure 2]]a and [[Figure 2]]b. A surgical attempt was performed at another hospital but was aborted due to excessive bleeding during dural opening. After the failure of the first surgery, she had neurological decline, and her TN was treated with maximum dose of carbamazepine, amitriptyline, and pregabalin. Gasserian ganglion radiofrequency ablation was also attempted to ease her pain. Despite all these efforts, her facial pain persisted and made her unable to eat solid food and to do other routine daily activities. She was recommended by the neurologist to get GKRS to treat her AVM, but due to the limited access to this service, she decided to visit our clinic.
![](https://www.thieme-connect.de/media/10.1055-s-00053244/202003/thumbnails/10-4103-ajns-ajns-229-20_293724-i293724-2.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
DSA showed a high-flow AVM with major feeders coming from the right SCA and right posterior cerebral artery, and major drainage was going through the superior petrosal vein to the transverse sinus [[Figure 2]]c and [[Figure 2]]d.
A simplified presigmoid approach modified by Juha Hernesniemi was performed to reach the AVM.[[6]] Intraoperative findings showed the superior and inferior divisions of the SCA feeding the AVM. A temporary clip was placed at the ambient segment of SCA. The AVM was circumferentially resected. The distal SCA branches feeding the AVM were coagulated and sectioned, and the SCA was mobilized from the fifth nerve. To ascertain the total decompression of the fifth nerve, we inserted a patch of Teflon surrounding the fifth nerve [[Figure 2]]e and [[Figure 2]]f.
Postoperatively, the patient experienced immediate pain relief with a mild-to-moderate degree of imbalance. The patient was discharged on postoperative day 7 with mRS 2 due to mild imbalance. Follow-up at 12 and 36 months showed that the patient was pain and medication free with mRS 1 due to her mild imbalance. Postoperative computed tomography angiography showed complete AVM removal [[Figure 2]]g and [[Figure 2]]h.
#
#
Discussion
The treatment for TN secondary cAVM still poses a great challenge. The difficulties arise from the need to address the neurovascular compression causing facial pain and concurrently address the formidable nature of a cAVM with a high risk of bleeding. The strong relation between the nerve compression and AVM makes it very rational to treat both conditions simultaneously. Due to its rarity and heterogeneity, no treatment consensus has been made to solve this problem, and one may not be practical either. Microsurgery, if feasible, offers a good option to completely remove the AVM and decompress the trigeminal nerve. However, in more complex cases, the treatment may need multimodality approaches to achieve a better clinical outcome. Of all treatment combinations, a combination of endovascular embolization and stereotactic radiosurgery seems to be the most favored one reported in the literature. Li et al. report only 15 cases of TN secondary to cAVM reported in the literature within the past 56 years including theirs.[[4]] Ten of these 15 cases were treated using embolization adjuvant therapy with satisfying pain outcome. Microsurgery by MVD was performed in five patients. Microsurgery for both MVD and AVM resection was only performed in three cases, and two of them were done in one surgery. Most of these surgeries resulted in an incomplete resection of the AVM, which exposes the patient to continued risk of hemorrhage from the AVM.
In addition, the AVM obliteration rate may not necessarily translate to TN relief. Intraoperative findings of our first case showed that even though most of AVM vessels were occluded [[Figure 1]]d, the trigeminal nerve was still significantly compressed by dilated lateral pontomesencephalic vein and the SCA [[Figure 1]]e. This situation explained the patient's persistent facial pain even though follow-up DSA showed significant obliteration on the AVM. A similar experience on GKRS outcome was also reported by Sato in 2003. In their case, the AVM nidus was still prominent 1 year after the GKRS, and the trigeminal nerve was still compressed by the arterialized veins.[[7]] Above all, the GKRS efficacy on cAVM treatment is time dependent and has been reported to have total obliteration rates of 40%–50% at 3-year follow-up and more than 70% at 5 years.[[8]],[[9]],[[10]] Therefore, in TN secondary to cAVM, GKRS alone for AVM treatment may not be adequate to cure the AVM. GKRS for classic TN has been well reported with poorer results compared to MVD. One systematic review of five prospective studies for the primary TN treatment showed that complete pain relief was achieved in 96% and 72% with MVD and GKRS, respectively.[[11]] In another meta-analyses comparing GKRS and MVD, short-term complete pain relief was achieved in 66% and 91%, respectively, and long-term complete pain relief was achieved in 44% and 69%, respectively.[[12]] The only downside of MVD was its postoperative complications that reached 11.6%.[[12]] Furthermore, in the case of TN secondary to cAVM, the risk of postoperative complications is presumably higher due to dilated vessels and arterialized veins which may obstruct the surgical corridor, compress the nerve, and are prone to rupture to potentially catastrophic hemorrhage. In 2017, a group from Beijing reported TN secondary to cAVM which was unrecognized before their first surgery. They had to terminate the MVD and eventually perform a successful second surgery 5 days later by combining AVM resection and MVD.[[4]] Our second case resembles their experience where the previous surgeons did not diagnose the AVM before the surgery and had to terminate the surgery after massive bleeding during dural opening. However, with adequate preparation, this case was successfully treated as has already been described above.
In our opinion, if the location and grading of the AVM can be safely accessed surgically, then surgery can be considered as one of the most effective ways to treat both the AVM and TN. Evidence shows that GKRS is a reasonable option to cure the AVM, but there are some concerns regarding the procedure. Concerns include the latency time to occlude the AVM, limited availability in developing countries, the possibility of post-GKRS extensive brain edema due to radiation necrosis or venous thrombosis, and finally, the efficacy of GKRS for TN reduces substantially over time.[[8]],[[12]],[[13]] Studies reported initial pain relief >90%, but it gradually decreasing to about 40%–70% after 5 years. AVM treatment through an endovascular approach is mostly performed as an adjuvant therapy to either surgery or GKRS. Curative embolization is only successful in 10%–20% of cases, and complication rates are over 30%.[[14]],[[15]],[[16]] Moreover, several factors such as higher cost, lack of pain relief, and lower rate of post-GKRS AVM obliteration after embolization made the treatment unappealing in most circumstances. As the case is relatively rare and AVMs are distinctly heterogeneous lesions, no adequate evidence will support a standard treatment algorithm. A tailored approach using a multimodality strategy based on clinical and social status should be embraced to treat this complex disease.
#
Conclusion
We have reported two cases of TN related to cAVMs that were successfully treated using a microsurgical approach. Microsurgical procedures offer an important treatment modality in managing TN secondary to cAVMs.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot bechrological order guaranteed.
#
#
#
Conflict of Interest
There are no conflicts of interest.
Financial support and sponsorship
Nil.
-
References
- 1 Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 2005;26 Suppl 2:s65-7.
- 2 Arnaout OM, Gross BA, Eddleman CS, Bendok BR, Getch CC, Batjer HH. Posterior fossa arteriovenous malformations. Neurosurg Focus 2009;26:E12.
- 3 Drake CG, Friedman AH, Peerless SJ. Posterior fossa arteriovenous malformations. J Neurosurg 1986;64:1-10.
- 4 Li ZY, Liang JT, Zhang HQ, Bao YH, Ling F. Trigeminal neuralgia caused by a dilated superior cerebellar artery and a draining vein of cerebellar arteriovenous malformations: A case report and review of the literature. Acta Neurochir (Wien) 2017;159:689-94.
- 5 Yuan Y, Zhang Y, Luo QI, Yu J. Trigeminal neuralgia caused by brain arteriovenous malformations: A case report and literature review. Exp Ther Med 2016;12:69-80.
- 6 Tjahjadi M, Niemelä M, Kivelev J, Serrone J, Maekawa H, Jahromi BR, et al. Presigmoid approach to vertebrobasilar artery aneurysms: A series of 31 patients and review of the literature. World Neurosurg 2016;92:313-22.
- 7 Sato K, Jokura H, Shirane R, Akabane T, Karibe H, Yoshimoto T. Trigeminal neuralgia associated with contralateral cerebellar arteriovenous malformation. Case illustration. J Neurosurg 2003;98:1318.
- 8 Bowden G, Kano H, Tonetti D, Niranjan A, Flickinger J, Lunsford LD. Stereotactic radiosurgery for arteriovenous malformations of the cerebellum. J Neurosurg 2014;120:583-90.
- 9 Cohen-Inbar O, Starke RM, Kano H, Bowden G, Huang P, Rodriguez-Mercado R, et al. Stereotactic radiosurgery for cerebellar arteriovenous malformations: An international multicenter study. J Neurosurg 2017;127:512-21.
- 10 Ding D, Starke RM, Yen CP, Sheehan JP. Radiosurgery for cerebellar arteriovenous malformations: Does infratentorial location affect outcome? World Neurosurg 2014;82:e209-17.
- 11 Sharma R, Phalak M, Katiyar V, Borkar S, Kale SS, Mahapatra AK. Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: A systematic review and meta-analysis of prospective comparative trials. Neurol India 2018;66:688-94.
- 12 Lu VM, Duvall JB, Phan K, Jonker BP. First treatment and retreatment of medically refractive trigeminal neuralgia by stereotactic radiosurgery versus microvascular decompression: A systematic review and Meta-analysis. Br J Neurosurg 2018;32:355-64.
- 13 Kim JW, Chung HT, Han MH, Kim DG, Paek SH. Brain edema after repeat gamma knife radiosurgery for a large arteriovenous malformation: A case report. Exp Neurobiol 2016;25:191-6.
- 14 Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589-97.
- 15 Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): A multicentre, non-blinded, randomised trial. Lancet 2014;383:614-21.
- 16 Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 2007;28:518-23.
Address for correspondence
Publikationsverlauf
Eingereicht: 11. Mai 2020
Angenommen: 04. Juli 2020
Artikel online veröffentlicht:
16. August 2022
© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 2005;26 Suppl 2:s65-7.
- 2 Arnaout OM, Gross BA, Eddleman CS, Bendok BR, Getch CC, Batjer HH. Posterior fossa arteriovenous malformations. Neurosurg Focus 2009;26:E12.
- 3 Drake CG, Friedman AH, Peerless SJ. Posterior fossa arteriovenous malformations. J Neurosurg 1986;64:1-10.
- 4 Li ZY, Liang JT, Zhang HQ, Bao YH, Ling F. Trigeminal neuralgia caused by a dilated superior cerebellar artery and a draining vein of cerebellar arteriovenous malformations: A case report and review of the literature. Acta Neurochir (Wien) 2017;159:689-94.
- 5 Yuan Y, Zhang Y, Luo QI, Yu J. Trigeminal neuralgia caused by brain arteriovenous malformations: A case report and literature review. Exp Ther Med 2016;12:69-80.
- 6 Tjahjadi M, Niemelä M, Kivelev J, Serrone J, Maekawa H, Jahromi BR, et al. Presigmoid approach to vertebrobasilar artery aneurysms: A series of 31 patients and review of the literature. World Neurosurg 2016;92:313-22.
- 7 Sato K, Jokura H, Shirane R, Akabane T, Karibe H, Yoshimoto T. Trigeminal neuralgia associated with contralateral cerebellar arteriovenous malformation. Case illustration. J Neurosurg 2003;98:1318.
- 8 Bowden G, Kano H, Tonetti D, Niranjan A, Flickinger J, Lunsford LD. Stereotactic radiosurgery for arteriovenous malformations of the cerebellum. J Neurosurg 2014;120:583-90.
- 9 Cohen-Inbar O, Starke RM, Kano H, Bowden G, Huang P, Rodriguez-Mercado R, et al. Stereotactic radiosurgery for cerebellar arteriovenous malformations: An international multicenter study. J Neurosurg 2017;127:512-21.
- 10 Ding D, Starke RM, Yen CP, Sheehan JP. Radiosurgery for cerebellar arteriovenous malformations: Does infratentorial location affect outcome? World Neurosurg 2014;82:e209-17.
- 11 Sharma R, Phalak M, Katiyar V, Borkar S, Kale SS, Mahapatra AK. Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: A systematic review and meta-analysis of prospective comparative trials. Neurol India 2018;66:688-94.
- 12 Lu VM, Duvall JB, Phan K, Jonker BP. First treatment and retreatment of medically refractive trigeminal neuralgia by stereotactic radiosurgery versus microvascular decompression: A systematic review and Meta-analysis. Br J Neurosurg 2018;32:355-64.
- 13 Kim JW, Chung HT, Han MH, Kim DG, Paek SH. Brain edema after repeat gamma knife radiosurgery for a large arteriovenous malformation: A case report. Exp Neurobiol 2016;25:191-6.
- 14 Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589-97.
- 15 Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): A multicentre, non-blinded, randomised trial. Lancet 2014;383:614-21.
- 16 Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 2007;28:518-23.
![](https://www.thieme-connect.de/media/10.1055-s-00053244/202003/thumbnails/10-4103-ajns-ajns-229-20_293724-i293724-1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
![](https://www.thieme-connect.de/media/10.1055-s-00053244/202003/thumbnails/10-4103-ajns-ajns-229-20_293724-i293724-2.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)